Biogen Inc.'s recent revelation of promising early data from an experimental Alzheimer's treatment is something of a breakthrough: it's the first time that we have seen positive human data about a new Alzheimer's drug that can both reduce the presence of amyloid plaques in the brain and improve cognitive function.
An Oscar for "Still Alice" is shining the brightest light yet on Alzheimer's, but light isn't enough anymore. Attention isn't enough. It's time to get serious. Alzheimer's is exerting a powerful impact on American families -- on our health, our finances, and our futures. And women are disproportionately impacted.
While the story is fiction, Julianne Moore's gripping portrayal of a person going through the stages of Alzheimer's disease in Still Alice is an all-too-real story faced every day by more than 5 million Americans and their caregivers. Her performance is a Hollywood reminder of why Alzheimer's research is so important.